C12N 2770/24152
Relating to complementing cells and packaging systems for producing virus or viral
Official title: relating to complementing cells and packaging systems for producing virus or viral particles
C12N2770/24152 (Relating to complementing cells and packaging systems for producing virus or viral) appears on 7 US grants and 18 published applications in this corpus.
Search patents in C12N- Granted patents
- 7
- Published applications
- 18
- Assignees
- 16
- Inventors
- 65
- Latest grant
- 28 Oct 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 1 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 1 | 1 |
| 2020 | 0 | 1 |
| 2021 | 1 | 3 |
| 2022 | 1 | 1 |
| 2023 | 2 | 0 |
| 2024 | 0 | 4 |
| 2025 | 1 | 2 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Vero cell line that can be suspension-cultured in serum-free medium, preparation method therefor, and method for preparing viruses for vaccines by using novel cell line28 Oct 2025US 12,454,680 B2SK Bioscience Co., Ltd.
- Engineered cells with decreased gene expression resulting in increased viral production23 May 2023US 11,655,471 B2University of Georgia Research Foundation, Inc.
- Chimeric insect-specific flaviviruses7 Feb 2023US 11,572,390 B2The University of Queensland
- Optimized Zika virus envelope gene and expression thereof6 Sep 2022US 11,434,261 B2Hawaii Biotech, Inc.
- Compositions and methods of vaccination against dengue virus in children and young adults18 May 2021US 11,007,261 B2Takeda Vaccines, Inc.
- Systems and Methods for Delivery of Viral Antigens8 Oct 2026US 2026/0306610 A1Veergen Inc.
- Compositions and methods of vaccination against dengue virus in children and young adults24 Jul 2025US 2025/0235522 A1Takeda Vaccines, Inc.
- Method for revaluating antibody-dependent enhancement reaction using pseudovirus6 Mar 2025US 2025/0076299 A1Japan as Represented by the Director-General of National Institute Institute of Infectious
- Large-scale flaviviral vaccine production and manufacture4 Jul 2024US 2024/0216498 A1Takeda Vaccines, Inc.
- Vaccine compositions and methods of use thereof16 May 2024US 2024/0156948 A1Excepgen Inc.
Most cited
By later US patents